Biblio
A clinical trial of treating androgenic alopecia with mesenchymal stem cell suspension derived from autologous hair follicle. Plast Reconstr Surg. 2023.
. Retinoic acid drives hair follicle stem cell activation via Wnt/β-catenin signalling in androgenetic alopecia. J Eur Acad Dermatol Venereol. 2024.